Medications for Multiple Sclerosis Relapsingremitting

15 results
  • betaseron - interferon beta-1b

    (Interferon Beta-1b)
    Bayer Healthcare Pharmaceuticals Inc.
    Betaseron treats relapsing forms of multiple sclerosis in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
  • briumvi - ublituximab injection, solution, concentrate

    (Ublituximab)
    Tg Therapeutics, Inc.
    BRIUMVI treats relapsing forms of multiple sclerosis (MS) in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
  • copaxone - glatiramer acetate injection, solution

    (Glatiramer Acetate)
    Teva Neuroscience, Inc.
    Copaxone treats relapsing forms of multiple sclerosis in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
  • fingolimod - fingolimod capsule

    (Fingolimod)
    Biocon Pharma Inc.
    Fingolimod treats relapsing forms of multiple sclerosis (MS) in patients aged 10 and older, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
  • kesimpta - ofatumumab injection, solution

    (Ofatumumab)
    Novartis Pharmaceuticals Corporation
    Kesimpta treats relapsing forms of multiple sclerosis in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
  • mavenclad - cladribine tablet

    (Cladribine)
    Emd Serono, Inc.
    Mavenclad treats relapsing forms of multiple sclerosis, including relapsing-remitting and active secondary progressive disease, in adults. It is generally recommended for patients with an inadequate response to or intolerance of other MS treatments. Not recommended for clinically isolated syndrome (CIS).
  • mayzent - siponimod tablet, film coated

    (Siponimod)
    Novartis Pharmaceuticals Corporation
    Mayzent treats relapsing forms of multiple sclerosis in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
  • ocrevus - ocrelizumab injection

    (Ocrelizumab)
    Genentech, Inc.
    Ocrevus treats relapsing forms of MS (including clinically isolated syndrome, relapsing-remitting, and active secondary progressive disease) and primary progressive MS in adults.
  • plegridy - peginterferon beta-1a injection, solution

    (Peginterferon Beta-1a)
    Biogen Inc.
    Plegridy treats relapsing forms of multiple sclerosis (MS) in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
  • ponvory - ponesimod tablet, film coated

    (Ponesimod)
    Janssen Pharmaceuticals, Inc
    Ponvory treats relapsing forms of multiple sclerosis in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.